Costly targeted cancer treatments challenge publicly-funded healthcare systems seeking to align expected benefit with value for money. In 2021, The Canadian Agency for Drugs and Technologies in Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results